Precirix (private company)
See something wrong or missing? Let us know
Offices:Bruxelles
Business model:B2B
Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.
Investors:
we tracked 9 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 87.95M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Precirix
Name | Criteria | |
---|---|---|
![]() |
Beckley Psytech
70%
|
|
![]() |
CatalYm
70%
|
|
![]() |
NMD Pharma
70%
|
|
![]() |
Salvia BioElectronics
70%
|
|
![]() |
Sanifit Therapeutics
70%
|
|
![]() |
Synendos Therapeutics
70%
|
|
![]() |
Cytoki Pharma
70%
|
|
![]() |
Causaly
70%
|
|
![]() |
Eyevensys
70%
|
|
![]() |
Cardior Pharmaceuticals
70%
|
|